Renounceable Issue
Filed with ASX ·
6ix hasn’t read this filing yet.
Later from Cyclopharm
- Technegas COPD Trial Update
- Offer Booklet for Renounceable Rights Issue
- Clinical Protocol Approval from US FDA
- Regulatory Approval in China
- Renewal of Debt Facility with National Australia Bank
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm